Download PDF
Tierarztl Prax Ausg K Kleintiere Heimtiere 2011; 39(06): 425-428
DOI: 10.1055/s-0038-1623607
Übersichtsartikel
Schattauer GmbH

Therapie der chronisch rezidivierenden idiopathischen Pyodermie des Hundes mit Staphylokokken-Vakzinen

Treatment of chronic recurrent idiopathic pyoderma in the dog with vaccines containing bacterial antigens
K. Glos
1   Tierärztliche Fachklinik für Kleintiere Haas & Link
,
R. S. Mueller
2   Medizinische Kleintierklinik, Zentrum für klinische Tiermedizin, Ludwig-Maximilians-Universität München
› Author Affiliations
Further Information

Publication History

Eingegangen: 04 November 2011

Akzeptiert nach Revision: 22 November 2011

Publication Date:
05 January 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Staphylokokken-Vakzinen sind eine sinnvolle therapeutische Alternative zur herkömmlichen antibakteriellen Therapie bei der chronisch rezidivierenden Pyodermie des Hundes ohne feststellbare zugrundeliegende Erkrankung. Zu Beginn der Therapie sollte die Vakzine für mehrere Wochen mit anderen antimikrobiellen Behandlungen kombiniert werden. Der Therapieerfolg einer solchen Vakzine sollte erst nach 10, besser 18 Wochen beurteilt werden. Die Herstellung der Vakzine hat maßgeblichen Einfluss auf die Nebenwirkungen und die Wirksamkeit.

Summary

Staphylococcal vaccines are a good therapeutic alternative to the classic antibacterial treatments in dogs with chronic recurrent pyoderma without detectable underlying diseases. At the beginning of this therapy, the vaccine should be combined with other antimicrobial treatments for several weeks. Treatment success should be judged after 10, or better, 18 weeks. Differences in the production processes of the vaccine will influence the adverse effects and the success rate.

Schlüsselwörter

Bakterielle Vakzine - chronisch wiederkehrende idiopathische Pyodermie - bakterielle Dermatitis - immunmodulierende Therapie

Key words

Bacterial vaccines - chronic recurrent idiopathic pyoderma - bacterial dermatitis - immunomodulatory therapy
 

  • Literatur

  • 1 Bannoehr J, Ben Zakour NL, Waller AS, Guardabassi L, Thoday KL, van den Broek AH. et al. Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains. J Bacteriol 2007; 189 (23) 8685-8692.
    CrossrefPubMedGoogle Scholar
  • 2 Becker AM, Janik TA, Smith EK, Sousa CA, Peters BA. Propionibacterium acnes immunotherapy in chronic recurrent canine pyoderma. An adjunct to antibiotic therapy. J Vet Int Med 1989; 03 (01) 26-30.
    PubMedGoogle Scholar
  • 3 Bell A. Prophylaxis of German Shepherd Recurrent Furunculosis (German Shepherd Dog Pyoderma) Using Cephalexin Pulse Therapy. Aust Vet Pract 1995; 25 (01) 30-36.
    PubMedGoogle Scholar
  • 4 Curtis C. Canine idiopathic recurrent superficial pyoderma. Vet Rec 1998; 143 (12) 344.
    PubMedGoogle Scholar
  • 5 Curtis CF, Lamport AI, Lloyd DH. Masked, controlled study to investigate the efficacy of a Staphylococcus intermedius autogenous bacterin for the control of canine idiopathic recurrent superficial pyoderma. Vet Dermatol 2006; 17 (03) 163-168.
    CrossrefPubMedGoogle Scholar
  • 6 Day MJ. Possible immunodeficiency in related rottweiler dogs. J Small Anim Pract 1999; 40 (12) 561-568.
    CrossrefPubMedGoogle Scholar
  • 7 DeBoer DJ, Moriello KA, Thomas CB, Schultz KT. Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs. Am J Vet Res 1990; 51 (04) 636-639.
    PubMedGoogle Scholar
  • 8 Foster AP. Immunomodulation and immunodeficiency. Vet Dermatol 2004; 15 (02) 115-126.
    CrossrefPubMedGoogle Scholar
  • 9 Helton-Rhodes K. Feline immunomodulators. In: Current Veterinary Therapy XII. Bonagura JD. ed. Philadelphia: Saunders; 1995: 581-584.
    Google Scholar
  • 10 Hill PB, Lo A, Eden CA, Huntley S, Morey V, Ramsey S. et al. Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice. Vet Rec 2006; 158 (16) 533-539.
    CrossrefPubMedGoogle Scholar
  • 11 Kwochka KW. Recurrent pyoderma. In: Current Veterinary Dermatology. Griffin CE. ed. Philadelphia: Mosby; 1993: 3.
    Google Scholar
  • 12 Löwenstein C. Pyodermie beim Hund. Tierärztl Prax 2011; 39 (K): 405-417.
    PubMedGoogle Scholar
  • 13 Mayr A, Selmair J, Schels H. Erfahrungen mit Autovakzine-Therapie bei der Staphylokokken-Pyodermie des Hundes. Tierärztl Umsch 1987; 42: 112-118.
    PubMedGoogle Scholar
  • 14 Rosser EJ. German Shepherd Dog pyoderma. Vet Clin North Am Small Anim Pract 2006; 36 (01) 203-211.
    CrossrefPubMedGoogle Scholar
  • 15 Schwarz S, Noble WC. Aspects of bacterial resistance to antimicrobials used in veterinary dermatological practice. Vet Dermatol 1999; 10 (03) 163-176.
    CrossrefPubMedGoogle Scholar
  • 16 Schwassman M. Uses of interferon. AAVD Newsletter. 1999: 9.
    Google Scholar
  • 17 Scott DW, Miller WH, Griffin CE. Muller and Kirk’s Small Animal Dermatology. 6th edn.. Philadelphia: Saunders; 2001
    Google Scholar
  • 18 Scott DW, Paradis M. A survey of canine and feline skin disorders seen in a university practice: Small Animal Clinic, University of Montréal, Saint-Hyacinthe, Québec (1987–1988). Can Vet J 1990; 31 (12) 830-835.
    PubMedGoogle Scholar
  • 19 Trepanier LA. Delayed hypersensitivity reactions to sulphonamides: syndromes, pathogenesis and management. Vet Dermatol 1999; 10 (03) 241-248.
    CrossrefPubMedGoogle Scholar
  • 20 Whitbread TJ, Batt RM, Garthwaite G. Relative deficiency of serum IgA in the german shepherd dog: a breed abnormality. Res Vet Sci 1984; 37 (03) 350-352.
    PubMedGoogle Scholar
  • 21 White SD, Carlotti DN, Pin D, Bonenberger T, Ihrke PJ, Monet E. et al. Putative drug-related pemphigus foliaceus in four dogs. Vet Dermatol 2002; 13 (04) 195-202.
    CrossrefPubMedGoogle Scholar
  • 22 White SD. Systemic treatment of bacterial skin infections of dogs and cats. Vet Dermatol 1996; 07 (03) 133-143.
    CrossrefPubMedGoogle Scholar